Iktos appoints new Scientific Advisory Board

To advance Iktos' vision, a new Scientific Advisory Board has been appointed, comprising of five world-renowned experts in AI-driven molecular design, lab automation, computational chemistry, first-in-human drug development, and strategic pipeline management. Their expertise will be instrumental in enhancing the AI-first drug discovery platform, strengthening collaborations, and advancing Iktos’ pipeline towards commercialization.

Click here to access our press release.